Article
Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal Metastasis.
Biomolecules - 19 Jul 2022
Bouzid Hayet, Soualmia Feryel, Oikonomopoulou Katerina, Soosaipillai Antoninus, Walker Francine, Louati Khaoula, Lo Dico Rea, Pocard Marc, El Amri Chahrazade, Ignatenko Natalia A, Darmoul Dalila
Abstract excerpt
Kallikrein-related peptidases (KLKs) are implicated in many cancer-related processes. KLK6, one of the 15 KLK family members, is a promising biomarker for diagnosis of many cancers and has been associated with poor prognosis of colorectal cancer (CRC) patients. Herein, we evaluated the expression and cellular functions of KLK6 in colon cancer-derived cell lines and in clinical samples from CRC patients. We showed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
